Please login to the form below

Not currently logged in
Email:
Password:

Kymab

This page shows the latest Kymab news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Biosimilars ready to pounce on Humira, Hong Kong could rival Nasdaq, Kymab's OX40 candidate

Daily Brief: Biosimilars ready to pounce on Humira, Hong Kong could rival Nasdaq, Kymab's OX40 candidate

Kymab reports early data from lead antibody. UK biotech company Kymab has released phase 1 data from its OX40-Ligand monoclonal antibody KY1005. ... Kymab says the data supports taking KY1005 into patient phase II studies in patients with atopic

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Kymab appoints its first chief medical officer Kymab appoints its first chief medical officer

    Dr Quaratino said: “Kymab’s emerging human antibody pipeline provides great potential to improve patient treatment options in our four main therapeutics areas of focus.". ... Dr David Chiswell, CEO of Kymab, said: “I am delighted to welcome Sonia

  • Dr Arndt Schottelius to lead Kymab’s R&D Dr Arndt Schottelius to lead Kymab’s R&D

    Cambridge, UK-based Kymab has appointed Dr Arndt Schottelius to the newly-created position of executive vice president of research and development. ... Dr David Chiswell, chief executive of Kymab, said: “I am delighted to welcome Dr Schottelius to the

  • Dr David Chiswell joins Kymab Dr David Chiswell joins Kymab

    Dr Chiswell said: “I have spent one of the most satisfying years of my career as interim CEO working closely with the excellent team at Kymab. ... I believe Kymab has all the tools needed to enable it to become a truly successful major biotech company.

  • Kymab names Anne Hyland as chief financial officer Kymab names Anne Hyland as chief financial officer

    Commenting on her appointment, Hyland said: “I am delighted to join Kymab at this exciting time. ... Anne's strong skill set will be invaluable as we build Kymab into a substantial global biopharmaceutical company.”.

More from appointments
Approximately 3 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics